Rachel Johns

524 total citations
9 papers, 324 citations indexed

About

Rachel Johns is a scholar working on Molecular Biology, Infectious Diseases and Cancer Research. According to data from OpenAlex, Rachel Johns has authored 9 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Cancer Research. Recurrent topics in Rachel Johns's work include RNA Interference and Gene Delivery (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and MicroRNA in disease regulation (2 papers). Rachel Johns is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and MicroRNA in disease regulation (2 papers). Rachel Johns collaborates with scholars based in United States and United Kingdom. Rachel Johns's co-authors include Shaguna Seth, Michael V. Templin, Ronald V. Maier, Patrick S. Stayton, Angela M. B. Collie, Jered Singleton, Dylan Guelig, Lorraine Lillis, Bernhard H. Weigl and David S. Boyle and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Neurology.

In The Last Decade

Rachel Johns

9 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel Johns United States	6	240	92	44	29	18	9	324
Muhammad Moazzam Pakistan	5	260 1.1×	56 0.6×	58 1.3×	25 0.9×	11 0.6×	13	355
Faye Walker United States	8	300 1.3×	111 1.2×	16 0.4×	25 0.9×	9 0.5×	12	403
Tulsi Ram Damase United States	5	403 1.7×	53 0.6×	92 2.1×	33 1.1×	20 1.1×	12	488
Angela Kragten Netherlands	10	204 0.8×	41 0.4×	66 1.5×	58 2.0×	44 2.4×	11	377
Haiyin Yang China	8	154 0.6×	60 0.7×	26 0.6×	42 1.4×	9 0.5×	12	265
Pattamawadee Yanatatsaneejit Thailand	10	264 1.1×	80 0.9×	26 0.6×	41 1.4×	18 1.0×	20	360
Shuwei Shen China	6	148 0.6×	155 1.7×	50 1.1×	50 1.7×	10 0.6×	10	299
Shuyan Huang United States	8	186 0.8×	72 0.8×	41 0.9×	10 0.3×	52 2.9×	10	342
Guojun Cao China	12	274 1.1×	65 0.7×	139 3.2×	14 0.5×	15 0.8×	24	390

Countries citing papers authored by Rachel Johns

Since Specialization

Citations

This map shows the geographic impact of Rachel Johns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Johns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Johns more than expected).

Fields of papers citing papers by Rachel Johns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Johns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Johns. The network helps show where Rachel Johns may publish in the future.

Co-authorship network of co-authors of Rachel Johns

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Johns. A scholar is included among the top collaborators of Rachel Johns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Johns. Rachel Johns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Malecová, Barbora, Rob S. Burke, Michael A. Cochran, et al.. (2023). Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs). Nucleic Acids Research. 51(12). 5901–5910. 75 indexed citations

Malecová, Barbora, David Sala, Rachel Johns, et al.. (2022). DUX4 siRNA Optimization for the Development of an Antibody-Oligonucleotide Conjugate (AOC) for the Treatment of FSHD (P17-13.009). Neurology. 98(18_supplement). 2 indexed citations

Singleton, Jered, Jennifer L. Osborn, Lorraine Lillis, et al.. (2014). Electricity-Free Amplification and Detection for Molecular Point-of-Care Diagnosis of HIV-1. PLoS ONE. 9(11). e113693–e113693. 69 indexed citations

Seth, Shaguna, Rachel Johns, & Michael V. Templin. (2012). Delivery and Biodistribution of siRNA for Cancer Therapy: Challenges and Future Prospects. Therapeutic Delivery. 3(2). 245–261. 45 indexed citations

Collie, Angela M. B., et al.. (2010). Differential monocyte/macrophage interleukin‐1β production due to biomaterial topography requires the β2 integrin signaling pathway. Journal of Biomedical Materials Research Part A. 96A(1). 162–169. 29 indexed citations

Vaish, Narendra K., Feng Chen, Shaguna Seth, et al.. (2010). Improved specificity of gene silencing by siRNAs containing unlocked nucleobase analogs. Nucleic Acids Research. 39(5). 1823–1832. 83 indexed citations

Johns, Rachel, Mohamed E. H. ElSayed, Volga Bulmuş, et al.. (2008). Mechanistic analysis of macrophage response to IRAK-1 gene knockdown by a smart polymer-antisense oligonucleotide therapeutic. Journal of Biomaterials Science Polymer Edition. 19(10). 1333–1346. 5 indexed citations

Song, Heng, Rachel Johns, George Griesgraber, Carston R. Wagner, & Cheryl L. Zimmerman. (2003). Disposition and Oral Bioavailability in Rats of an Antiviral and Antitumor Amino Acid Phosphoramidate Prodrug of AZT-Monophosphate. Pharmaceutical Research. 20(3). 448–451. 11 indexed citations

Ferguson, Brian S., Hugh Gravelle, Mark Dusheiko, Matt Sutton, & Rachel Johns. (2002). Variations in practice admission rates: the policy relevance of regression standardisation. Journal of Health Services Research & Policy. 7(3). 170–176. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact